In April, we chatted with John J. Cannell, M.D., about the function of vitamin D and the recent developments that affect our need to increase our dietary intake of vitamin D. This month, we will discuss optimizing our vitamin D intake.
The Institute of Medicine (IOM) has published its new recommendation for the dietary intake of vitamin D. The new recommendations contain significant changes from IOM’s previous recommendations in 1997, and current research indicates that even the new changes are already out of date. During the next few months, we will chat with the executive director of The Vitamin D Council, John J. Cannell, M.D., about vitamin D and new research.
Many of your customers are tired of being tired. It seems that today’s world has produced more tired people than anything else. It goes beyond the fact that the large baby boomer generation is aging; rather, it is due to several factors.
February is “Heart Month” and I am delighted to bring some “breaking news,” as they like to say on TV, about cardiovascular health. Actually, it is not yet news because it is still in scheduled for publication with a scientific journal.
Pycnogenol is one of the most important, useful and researched dietary supplements. I first reported on Pycnogenol in this column in 1991 and have gone on to write six books on Pycnogenol (1–7). Scientists continue to expand the pool of published scientific research about this unique blend of bioflavonoid-related nutrients extracted from a specific plant species (Pinus maritime, the Maritime Pine that grows exclusively along the coast of southwest France) by a patented process that concentrates specific antioxidant and anti-inflammatory nutrients. Therefore, it is important to keep readers abreast of the extensive ongoing research on Pycnogenol.
In September, consumers and the dietary supplement industry achieved a major victory in the pursuit of good health. On September 28, 2010, the U.S. Food and Drug Administration (FDA) and a coalition of health practitioners, scientists and manufacturers, including the Alliance for Natural Health (ANH), agreed on the wording for qualified health claims for selenium against various forms of cancer.
The U.S. Food and Drug Administration (FDA) just agreed to new Qualified Health Claims for selenium. The law firm of Emord & Associates announced on September 28 that a partial settlement with FDA has been achieved following the decision of the U.S. District Court for the District of Columbia in ANH v. Sebelius.